Pipeline
swipeSwipe to right or left
- Category
- Progress
- Pre-clinical
- Phase 1
- Phase 2
- Phase 3
| Newly Diagnosed Ovarian Cancer | Oregovomab + Chemotherapy (Paclitaxel, Carboplatin) | Phase III on-going | |
| [Oregovomab + Neoadjuvant Chemotherapy] --> Interval Debulking Surgery --> [Oregovomab + Chemotherapy] | Phase II on-going | ||
| Recurrent Ovarian Cancer | Oregovomab + Niraparib (Zejula) | Phase II on-going | |
| Oregovomab + Bevacizumab + Chemotherapy | Phase 1b/2 on-going | ||
| Oregovomab + Pegylated Liposomal Doxorubicin (PLD) or Weekly Paclitaxel | Phase 1b/2 on-going | ||
| Pancreatic Cancer | BrevaRex (MAb-AR20.5) + Chemotherapy | Phase 1 completed/Phase 2 planned |
- Canariabio Inc.
- CEO : Michael Hannik Na
- E-mail : contact@canariabio.com
- © CANARIABIO INC. All Rights Reserved.
